This revealed that 60.4% of AD-risk single-nucleotide polymorphisms are highly expressed by microglia [212, 364], including Apoe, Trem2, Abca7, Cd33 and Cr1 [221]. This evidence concerns the gene CD33 and Alzheimer disease.